BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 20957845)

  • 21. Evaluation of the safety of modafinil for treatment of excessive sleepiness.
    Roth T; Schwartz JR; Hirshkowitz M; Erman MK; Dayno JM; Arora S
    J Clin Sleep Med; 2007 Oct; 3(6):595-602. PubMed ID: 17993041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea.
    Ronnebaum S; Bron M; Patel D; Menno D; Bujanover S; Kratochvil D; Lucas E; Stepnowsky C
    J Clin Sleep Med; 2021 Dec; 17(12):2543-2555. PubMed ID: 34402784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of shift duration on the efficacy and tolerability of armodafinil in patients with excessive sleepiness associated with shift work disorder.
    Harsh J; Yang R; Hull SG
    Curr Med Res Opin; 2014 May; 30(5):945-51. PubMed ID: 24450538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of armodafinil on simulated driving and self-report measures in obstructive sleep apnea patients prior to treatment with continuous positive airway pressure.
    Kay GG; Feldman N
    J Clin Sleep Med; 2013 May; 9(5):445-54. PubMed ID: 23674935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of modafinil for improving daytime wakefulness in patients treated previously with psychostimulants.
    Schwartz JR; Feldman NT; Fry JM; Harsh J
    Sleep Med; 2003 Jan; 4(1):43-9. PubMed ID: 14592359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Wakefulness-Promoting Agents on Sleepiness in Patients with Sleep Apnea Treated with CPAP: A Meta-Analysis.
    Sukhal S; Khalid M; Tulaimat A
    J Clin Sleep Med; 2015 Oct; 11(10):1179-86. PubMed ID: 25979103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome.
    Black JE; Hirshkowitz M
    Sleep; 2005 Apr; 28(4):464-71. PubMed ID: 16171291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of armodafinil on simulated driving and alertness in shift work disorder.
    Drake C; Gumenyuk V; Roth T; Howard R
    Sleep; 2014 Dec; 37(12):1987-94. PubMed ID: 25325498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic approaches for the management of symptoms and cardiovascular consequences of obstructive sleep apnea in adults.
    Dopp JM; Morgan BJ
    Sleep Breath; 2010 Dec; 14(4):307-15. PubMed ID: 20582741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness.
    Schwartz JR; Nelson MT; Schwartz ER; Hughes RJ
    Clin Neuropharmacol; 2004; 27(2):74-9. PubMed ID: 15252267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Armodafinil in the treatment of excessive sleepiness.
    Rosenberg R; Bogan R
    Nat Sci Sleep; 2010; 2():95-105. PubMed ID: 23616702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modafinil in the treatment of excessive daytime sleepiness.
    Valentino RM; Foldvary-Schaefer N
    Cleve Clin J Med; 2007 Aug; 74(8):561-6, 568-71. PubMed ID: 17708127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group.
    Ann Neurol; 1998 Jan; 43(1):88-97. PubMed ID: 9450772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Healthcare costs among patients with excessive sleepiness associated with obstructive sleep apnea, shift work disorder, or narcolepsy.
    Carlton R; Lunacsek O; Regan T; Carroll CA
    Am Health Drug Benefits; 2014 Sep; 7(6):334-40. PubMed ID: 25558302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modafinil/armodafinil in obstructive sleep apnoea: a systematic review and meta-analysis.
    Chapman JL; Vakulin A; Hedner J; Yee BJ; Marshall NS
    Eur Respir J; 2016 May; 47(5):1420-8. PubMed ID: 26846828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modafinil in the treatment of excessive sleepiness.
    Schwartz JR
    Drug Des Devel Ther; 2009 Feb; 2():71-85. PubMed ID: 19920895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
    Black J; Houghton WC
    Sleep; 2006 Jul; 29(7):939-46. PubMed ID: 16895262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy.
    Becker PM; Schwartz JR; Feldman NT; Hughes RJ
    Psychopharmacology (Berl); 2004 Jan; 171(2):133-9. PubMed ID: 14647965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of adjunctive modafinil treatment on residual excessive daytime sleepiness among nasal continuous positive airway pressure-treated japanese patients with obstructive sleep apnea syndrome: a double-blind placebo-controlled study.
    Inoue Y; Takasaki Y; Yamashiro Y
    J Clin Sleep Med; 2013 Aug; 9(8):751-7. PubMed ID: 23946704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Armodafinil and modafinil in patients with excessive sleepiness associated with shift work disorder: a pharmacokinetic/pharmacodynamic model for predicting and comparing their concentration-effect relationships.
    Darwish M; Bond M; Ezzet F
    J Clin Pharmacol; 2012 Sep; 52(9):1328-42. PubMed ID: 22039290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.